Prostatis Group’s Philip Morris PM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$687K Sell
4,157
-126
-3% -$21.9K 0.18% 90
2025
Q4
$687K Buy
4,283
+2,412
+129% +$374K 0.16% 88
2025
Q3
$303K Buy
1,871
+1
+0.1% +$168 0.08% 127
2025
Q2
$341K Buy
1,870
+75
+4% +$12.9K 0.1% 111
2025
Q1
$285K Buy
1,795
+10
+0.6% +$1.42K 0.09% 124
2024
Q4
$215K Buy
+1,785
New +$225K 0.06% 147
2024
Q3
Sell
-2,418
Closed -$245K 145
2024
Q2
$245K Buy
+2,418
New +$236K 0.09% 129
2023
Q3
Sell
-97,805
Closed -$116K 192
2023
Q2
$116K Buy
+97,805
New +$9.34M 0.05% 132

Other funds holding PM

Prostatis Group's PM Position: Q1 2026 in Review

Prostatis Group reduced its Philip Morris (PM) stake by 2.9% in Q1 2026, selling an estimated $21.9K and leaving 4,157 shares worth $687K. The position accounts for 0.18% of the portfolio, ranked #90.

Prostatis Group first reported a position in PM in Q2 2023 and has held it in 8 quarters since. 2,852 funds tracked by Wall St. Rank hold PM as of Q1 2026.

  • Prostatis Group held 4,157 shares of Philip Morris worth $687K as of Q1 2026.
  • Prostatis Group sold 126 Philip Morris shares in Q1 2026, an estimated $21.9K.
  • Philip Morris made up 0.18% of Prostatis Group's portfolio in Q1 2026, its #90 holding.
  • Prostatis Group first reported a position in Philip Morris in Q2 2023 and has held it in 8 quarters since.
  • 2,852 funds tracked by Wall St. Rank held Philip Morris as of Q1 2026.

Based on Prostatis Group's 13F filing for Q1 2026, filed 12 May 2026.